The Cooper Companies, Inc. Common Stock (COO) Stock Price

COOStockS&P 500

$57.94−19.03%52W

Market Cap$11.02B

P/E29.39x

PEG Ratio0.54

Div yield0.02%

Beta0.82

COO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-29.00%

Price vs S&P 500 (4W)8.38%

PEG Ratio0.54

VGM Score57.24

P/E Ratio (Annual)29.39x

Indicated Dividend Yield (Annual)0.02%

P/CF (Annual)13.84x

Book Value / Share (Quarterly)$43.81

P/TBV (Annual)2.09x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.35%

Cash Flow / Share (Quarterly)$3.57

Payout Ratio (TTM)1.63%

Price vs S&P 500 (YTD)-41.23%

Gross Margin (TTM)65.93%

Net Profit Margin (TTM)13.46%

EPS (TTM)$2.93

10-Day Avg Trading Volume3.76M

EPS Excl Extra (TTM)$2.93

Revenue Growth (5Y)10.98%

EPS (Annual)$1.87

Dividend / Share (Annual)$0.00

ROI (Annual)3.49%

Gross Margin (Annual)65.54%

Net Profit Margin (5Y Avg)27.97%

Cash / Share (Quarterly)$0.81

P/E Basic Excl Extra (TTM)19.32x

Revenue Growth QoQ (YoY)0.56%

EPS Growth (5Y)9.30%

P/E Normalized (Annual)29.39x

ROA (Last FY)3.02%

Revenue Growth TTM (YoY)4.73%

EBITD / Share (TTM)$3.76

ROE (5Y Avg)12.22%

Operating Margin (TTM)12.84%

Cash Flow / Share (Annual)$2.21

P/B Ratio1.32x

P/B Ratio (Quarterly)1.69x

Net Income / Employee (Annual)$25,000

EV / Revenue (TTM)3.16x

Net Interest Coverage (TTM)6.25x

ROA (TTM)4.56%

EPS Growth QoQ (YoY)355.30%

EV / EBITDA (TTM)18.20x

EPS Incl Extra (Annual)$1.87

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.51x

3-Month Avg Trading Volume3.18M

52-Week Price Return-19.03%

EV / Free Cash Flow (Annual)30.91x

P/E Incl Extra (TTM)19.32x

Revenue / Employee (TTM)$282,500

Tangible BV / Share (Quarterly)$36.20

P/S Ratio (Annual)2.69x

Asset Turnover (Annual)0.33x

52-Week High$89.83

Operating Margin (5Y Avg)16.46%

EPS Excl Extra (Annual)$1.87

CapEx CAGR (5Y)3.15%

Tangible BV CAGR (5Y)21.28%

26-Week Price Return-19.09%

Quick Ratio (Annual)0.84x

13-Week Price Return-19.20%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.22x

Enterprise Value$13.41B

Revenue / Share Growth (5Y)10.80%

Asset Turnover (TTM)0.34x

Book Value / Share Growth (5Y)16.65%

Revenue / Employee (Annual)$272,800

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)13.84%

Cash / Share (Annual)$0.56

3-Month Return Std Dev39.83%

Gross Margin (5Y Avg)66.04%

Net Income / Employee (TTM)$38,000

EBITDA CAGR (5Y)14.46%

EBITDA Interim CAGR (5Y)14.15%

ROE (Last FY)4.55%

Net Interest Coverage (Annual)5.78x

EPS Basic Excl Extra (Annual)$1.87

P/FCF (TTM)16.25x

Receivables Turnover (TTM)5.36x

EV / Free Cash Flow (TTM)19.77x

Total Debt / Equity (Quarterly)0.31x

EPS Incl Extra (TTM)$2.93

Receivables Turnover (Annual)5.29x

ROI (TTM)5.28%

P/S Ratio (TTM)2.60x

Pretax Margin (5Y Avg)14.29%

Revenue / Share (Annual)$20.46

Tangible BV / Share (Annual)$33.96

Forward P/E11.83x

Free OCF CAGR (5Y)19.74%

Price vs S&P 500 (52W)-34.56%

P/E Ratio (TTM)19.32x

EPS Growth TTM (YoY)44.17%

Year-to-Date Return-29.31%

5-Day Price Return4.31%

EPS Normalized (Annual)$1.87

ROA (5Y Avg)8.55%

Net Profit Margin (Annual)9.16%

Month-to-Date Return2.49%

Cash Flow / Share (TTM)$12.84

EBITD / Share (Annual)$4.41

EPS Growth (3Y)-1.15%

Operating Margin (Annual)16.69%

LT Debt / Equity (Annual)0.30x

P/CF (TTM)10.66x

ROI (5Y Avg)9.79%

P/E Excl Extra (TTM)19.32x

LT Debt / Equity (Quarterly)0.23x

EPS Basic Excl Extra (TTM)$2.93

P/TBV (Quarterly)2.05x

Payout Ratio (Annual)0.78%

P/B Ratio (Annual)1.69x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)1.61x

Pretax Margin (TTM)10.91%

Book Value / Share (Annual)$42.06

Price vs S&P 500 (13W)-21.89%

Net Margin Growth (5Y)-1.36%

Dividend Yield (TTM)0.00%

Beta0.82x

P/FCF (Annual)25.40x

Revenue / Share (TTM)$21.91

ROE (TTM)6.88%

52-Week Low$51.01

vGradeB

gGradeB

mGradeC

vgmGradeC

COO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Sep 9, 2026	$1.12	$1.15	+2.67%(+$0.03)
Q1 2026	Jun 4, 2026	$1.09	$1.21	+10.52%(+$0.12)
Q4 2025	Mar 5, 2026	$1.03	$1.10	+7.05%(+$0.07)
Q3 2025	Dec 4, 2025	$1.11	$1.15	+3.29%(+$0.04)
Q2 2025	Aug 27, 2025	$1.07	$1.10	+3.04%(+$0.03)

COO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.75

3.83

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
COOThe Cooper Companies, Inc. Common Stock	B	B	C	29.4x	6.9%	11.0%	0.0%	$57.94
ALCAlcon Inc. Ordinary Shares	C	C	C	34.1x	2.9%	8.8%	0.3%	$66.18
BLCOBausch + Lomb Corporation	B	D	B	—	-2.7%	8.4%	—	$16.49
WRBYWarby Parker Inc.	D	B	C	1711.4x	2.1%	17.2%	—	$23.34
EYENational Vision Holdings, Inc. Common Stock	A	D	C	46.6x	5.7%	3.0%	—	$17.43
STAAStaar Surgical Co	D	B	C	—	1.1%	7.9%	—	$21.27
RXSTRxSight, Inc. Common Stock	B	C	D	—	-17.4%	55.7%	—	$4.51
LUCYInnovative Eyewear, Inc. Common Stock	B	A	D	—	-88.9%	113.5%	—	$0.79
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	F	—	—	—	—	$0.03

About The Cooper Companies, Inc. Common Stock

CooperCompanies operates two leading market segments: CooperVision, which controls approximately 25% of the U.S. contact lens market with brands including Proclear and Biofinity, and CooperSurgical, a reproductive healthcare company with 17% market share in U.S. IUDs and comprehensive IVF device coverage. The company benefits from strong positions in both recurring consumer products and specialized medical devices. CooperVision maintains one of the world's most extensive specialty lens portfolios, while CooperSurgical offers integrated fertility solutions across the IVF cycle.